Thank you for your interest in our RegActiv products
Feb 2018;42:38-46
1 Introduction Cardiovascular disease (CVD) is the leading cause of mortality worldwide, accounting for nearly one-third of global deaths each year ( The appeal of these agents stems from their capacity to modulate key pathophysiological contributors in atherosclerosis and heart failure, including oxidative stress, chronic vascular inflammation, endothelial dysfunction, dyslipidemia, and mitochondrial energy deficits ( However, the field is marked by heterogeneous and sometimes contradictory evidence
Human aging, muscle mass, and fiber type composition
We incorporate this master antioxidant into our IV therapies, delivering it directly to your cells for maximum impact
elucidated that overexpression of lncRNA-TUG1 led to a significant proliferation of GC tissue (most likely) by inhibiting miR-144